<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ISARIC CCP ARChetype CRF Creation Guidelines</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            background: #f4f4f9;
            margin: 0;
            padding: 0;
            line-height: 1.6;
            color: #333;
        }
        header {
            background: rgb(186, 2, 37);
            color: #fff;
            padding: 20px 0;
            text-align: center;
            position: relative;
        }
        header img {
            position: absolute;
            left: 20px;
            top: 10px;
            width: 60px;
            height: auto;
            cursor: pointer;
        }
        header h1 {
            color: #fff;
            margin: 0;
            font-size: 2em;
        }

        a:link, a:visited {
 
  text-decoration: none;
  cursor: auto;
}
             .container {
            max-width: 1000px;
            margin: 20px auto;
            padding: 20px;
            background: #fff;
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.1);
            overflow: auto;
        }
        .floating-box {
            width: 200px;
            padding: 10px;
            background: rgb(186, 2, 37);
            color: #fff;
            float: left;
            margin: 10px 20px 10px 0;
            border-radius: 8px;
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        h2 {
            color: rgb(186, 2, 37);
        }
            table {
      width: 100%;
      border-collapse: collapse;
      margin-bottom: 1em;
    }
            .red-button {
      background-color: #f44336; /* Red background */
      color: white;              /* White text */
      padding: 1px 1px;        /* Padding for size */
      text-align: center;        /* Centered text */
      text-decoration: none;     /* Remove underline */
      display: inline-block;     /* Inline-block for button-like appearance */
      border-radius: 2px;        /* Rounded corners */
      font-weight: bold;         /* Bold text */
      font-family: Arial, sans-serif; /* Font style */
      transition: background-color 0.3s ease; /* Smooth hover transition */
    }

    .red-button:hover {
      background-color: rgb(186, 2, 37); /* Darker red on hover */
    }
    th, td {
      border: 1px solid #aaa;
      padding: 8px;
      vertical-align: top;
    }
    th {
      background-color: #f2f2f2;
    }
        td:first-child {
  background-color: #f2f2f2;
}

        table thead th:nth-child(1) {
    width: 30%;
}

table thead th:nth-child(2),
table thead th:nth-child(3) {
    width: 35%;
}
    .note {
      font-size: 0.9em;
      color: #333;
      font-style: italic;
    }
    .crf-link {
      margin-left: 6px;
      text-decoration: none;
      font-size: 1em;
    }
    .dark-grey {
      color: #e59866;
    }
        .timeline {
            display: flex;
            flex-direction: column;
            gap: 20px;
            padding: 20px;
            border-left: 4px solid rgb(186, 2, 37);
            margin-left: 20px;
        }
        .timeline-item {
            background: #f2f2f2;
            padding: 15px;
            border-radius: 6px;
            position: relative;
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.1);
        }
        .timeline-item::before {
            content: "";
            position: absolute;
            left: -32px;
            top: 15px;
            width: 16px;
            height: 16px;
            background: rgb(186, 2, 2);
            border-radius: 50%;
        }
        .timeline-item h3 {
            margin: 0;
            font-size: 1.2em;
        }
        .timeline-item p {
            margin: 5px 0 0;
            font-size: 0.95em;
        }
        .footer {
            background: rgb(186, 2, 37);
            color: #fff;
            text-align: center;
            padding: 10px 0;
            margin-top: 20px;
        }
           @media screen and (max-width: 600px) {
      .floating-box {
        float: none;
        width: 100%;
        margin: 10px 0;
      }
    }
    </style>
     <script>
        function loadTime() {
            document.getElementById("demo").innerHTML = document.lastModified;
        }
    </script>
</head>
<body onload="loadTime();">

    <header>
        <!-- Clickable Logo -->
        <a href="https://www.isaric.org" target="_blank">
            <img src="assets/ISARIC_red-logo.png" alt="ISARIC Logo">
        </a>
        <h1 style="color:White">ISARIC CCP ARChetype Case Report Form </h1>
    </header>
 <div class="container">

         <section id="ARChetype CRFs">
       
            <p> ARChetype CRFs are standardized, disease or syndrom-specific CRFs developed by ISARIC. They are a key component of the <a href="https://isaric.org/resources/clinical-characterisation-protocol/"> 
                ISARIC-WHO Clinical Characterisation Protocol (CCP) </a> framework, which aims to enhance global preparedness and response to infectious disease outbreaks. 
                These CRFs are designed to address key clinical research questions, facilitating the collection of high-quality, harmonized data across 
                different regions and healthcare settings. By focusing on priority emerging and infectious diseasesâ€”such as mpox, Dengue, COVID-19, and H5Nxâ€”and related 
                syndromes, ARChetype CRFs support rapid, coordinated research efforts that can inform patient care and public health strategies. </p>

             <p>  ARChetype CRFs are designed to collect data on community or hospitalised patients in order to address key clinical research questions and 
                 inform better case management, contribute to the design of clinical trials, and guide public health interventions. </p>
                 <ul>
                    <li>Characterise the clinical epidemiology of cases, including the presenting signs and symptoms, disease progression, and clinical outcomes;
                    <li>Enable comparative clinical epidemiology between diseases, populations, and/or geographies;</li>
                    <li>Identify risk factors associated with disease presentation, progression and outcomes;</li>
                    <li>Describe the clinical management of patients, including any differences in approaches to management;</li>
                    <li>Describe diagnostic approaches and results; </li>
                     </ul>
            <p> Existing and inâ€‘development ARChetype CRFs are summarized in the table below, and the creation process is described afterward.</p>

   
  <table>
    <thead>
      <tr>
        <th> ARChetype CRFs <br>  (Available and <span class="dark-grey"> under creation </span> )</th>
        <th>Syndromic</th>
        <th>Disease Specific</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td><strong>Respiratory Infections</strong></td>
        <td>
          <strong>ARI Syndrome</strong> â€“ Hospitalised Population <a href="https://bridge.isaric.org/main/?param=ARChetype%20Syndromic%20CRF_ARI " class="red-button" title="CRF link">ðŸ“„</a> <br> 
         <span class="dark-grey"> + Pregnant Women and Children module</span> 
          
        </td>
        <td>
          <strong>Covid</strong> â€“ Hospitalised patients <a href="https://bridge.isaric.org/main?param=ARChetype%20Disease%20CRF_Covid" class="red-button" title="CRF link">ðŸ“„ </a> <br> 
          <strong>H5Nx</strong> â€“ Hospitalised patients <a href="https://bridge.isaric.org/main?param=ARChetype%20Disease%20CRF_H5Nx" class="red-button" title="CRF link">ðŸ“„  </a> 
        </td>
      </tr>
      <tr>
        <td> <strong>Haemorrhagic Febrile Infections (viral)</strong></td>
        <td>
          <span class="dark-grey"> <strong>Viral Haemorrhagic Fever (VHF)</strong> â€“ Hospitalised Population </span>
        </td>
        <td>
          <strong>Dengue</strong> â€“ Hospitalised patients <a href="https://bridge.isaric.org/main?param=ARChetype%20Disease%20CRF_Dengue" class="red-button" title="CRF link">ðŸ“„  </a> <br> 
         <span class="dark-grey"> <strong>Yellow Fever</strong> â€“ Hospitalised patients </span>
        </td>
      </tr>
      <tr>
        <td><strong>Arboviral Infections</strong></td>
        <td>
         <span class="dark-grey"> <strong>Arbovirus</strong> â€“ Community patients</span>
        </td>
        <td>
           <span class="dark-grey">  <strong>Oropouche</strong> â€“ Hospitalised patients<br>
         + Pregnant Women and Children module</span>
            <span class="dark-grey"> <strong>Chikungunya</strong> â€“ Hospitalised patients</span>
      
        </td>
      </tr>
      <tr>
        <td><strong>Brain Infections</strong></td>
        <td>
         <span class="dark-grey">  <strong>Encephalitis</strong> â€“ Hospitalised Population </span>
        </td>
        <td></td>
      </tr>
      <tr>
        <td><strong>Mucocutaneous Infections</strong></td>
        <td>
         
           </td>
        <td>
          <strong>Mpox</strong> â€“ Hospitalised Population <a href="https://bridge.isaric.org/main?param=ARChetype%20Disease%20CRF_Mpox" class="red-button" title="CRF link">ðŸ“„</a> <br>  
             <span class="dark-grey"> + Pregnant Women and Children module</span>
        </td>
      </tr>
          <tr>
        <td><strong>Sexual Transmitted Infections</strong></td>
        <td>
         <span class="dark-grey">  <strong>Sexual Transmitted Infections</strong> </span>
        </td>
        <td></td>
      </tr>
    </tbody>
  </table>

  <p>  Existing ARChetype CRFs are now available and ready to use on <a href="https://bridge.isaric.org/">  BRIDGE </a>  by clicking on the CRF icons <a href="" class="red-button" title="CRF link">ðŸ“„</a>  above. </p>
    <p> For instructions, see <a href="https://isaricresearch.github.io/Training/bridge_template_link.html">our guide to using ISARIC ARChetype CRFs in BRIDGE</a>.</p>
           <p>   ISARIC can host and manage your data on the ISARIC REDCap system, which offers standardized, pre-built databases aligned with all ARChetype CRFs. Contact us at <a href="mailto:data@isaric.org">data@isaric.org</a>.</p>

    </section>

<h1> Creation Guidelines </h1>

            <h2>Background</h2>
            <p> The ISARIC-WHO Clinical Characterisation Protocol (CCP) framework is a global, inclusive initiative offering a comprehensive approach for the rapid and standardised 
                characterisation of (re)emerging infectious diseases. Within this framework, ISARIC supports researchers by providing a suite of standardised tools, including protocols, 
                ARChetype case report forms (CRFs), and a CRF generator (<a href="https://bridge.isaric.org/">  BRIDGE </a>) that allows forms to be tailored to local 
                needs while ensuring consistent data collection. These tools utilise uniform questions, choices, and terminology, ensuring machine-readable, high-quality data across studies.
                Moreover,<a href="https://isaric.org/resources/data/"> ISARIC Clinical Epidemiology Platform </a> offers resources for efficient data capture and management and
                has developed an automated pipeline that can generate dashboards and results, aiding in the analysis of data and dissemination of evidence. </p>
                <p>Central coordination by ISARIC promotes streamlined communication and collaboration among researchers, enhancing the efficiency and effectiveness of research efforts.
                Researchers also benefit from the experience and expertise of a global network of ISARIC collaborators. This network facilitates coordinated research efforts and enhances
                the collective response to infectious disease outbreaks.</p>

            
        </section>

        <section id="objectives">
            <h2>CRF Creation Methodology</h2>
            <p>
                The ISARICâ€™s methodology for developing archetype CCP CRFs, emphasises essential stages from initial identification of the need, through to final release and establishment of 
                ongoing feedback mechanisms. </p>
               <p> <i> Please note that the guidelines will be adapted to reflect the context of the epidemic and disease.</i> </p>
               <p> <i> If you have any modifications to suggest for an existing CRF, or would like to know more about a CRF under development, please contact us at  <a href="mailto:data@isaric.org">data@isaric.org</a>.</i> </p>
            
        </section>

        <section id="process">
          
            <div class="timeline">
                        <!-- PHASE 1 -->
                 <div class="timeline-phase">
            <h2 class="phase-title">Phase 1. Initiation and Endorsement</h2>
                <div class="timeline-item">
                    <h3>1. Identify the Need</h3>
                    <p>Any ISARIC staff or research partner may propose the development of a new CRF. The justification, specific requirements, and objectives of the CRF can be proposed to the ISARIC CCP team at <a href="mailto:data@isaric.org">data@isaric.org</a>. </p>
                </div>
                <div class="timeline-item">
                    <h3>2. Endorsement of Action</h3>
                    <p>Where the topic is outside of the scope of ISARICâ€™s activities, the CCP Coordinator will liaise with the ISARIC ARChetype CRFs Approvers Commmittee to obtain a decision on endorsement and progression of CRF development. 
                        They will consider (a) the public health impact of the disease/syndrome, (b) existing research efforts to address the objectives proposed, (c) engagement of appropriate stakeholders (d) ISARICâ€™s ability to add unique value to global evidence generation efforts through development of the CRF. 
                    <p><i>Note:  activities 3-7 below may be initiated in parallel to the endorsement process to speed up the process in the event of an active outbreak. </i></p>
                    </p>
                </div>
                <div class="timeline-item">
                    <h3>3. Roles and Responsibilities </h3>
                    <p>The Initiator of the CRF oversees the creation process in collaboration with the CCP Coordinator. The final version of the CRF will then be approved by the ISARIC ARChetype CRFs Approvals Committee.</p>
                </div>
                <div class="timeline-item">
                    <h3>4. Identify Experts Reviewers</h3>
                    <p>In consultation with the ISARIC ARChetype CRFs Approvals Committee, the CRF Initiator will identify relevant Stakeholders including subject matter experts, partners in affected regions, 
                        researchers who have published relevant literature on the disease, clinicians with patient management experience, data managers, related global health actors, and regulatory bodies who will be invited to provide input and ensure alignment with diverse requirements. 
                        The Initiator will identify a subset of Experts whose input would most benefit an early stage of CRF iteration and designate them as â€˜Expert Reviewersâ€™.  </p>
                </div>
                <div class="timeline-item">
                    <h3>5. Identify Relevant Literature and Projects</h3>
                    <p>The Initiator, supported by the CCP Coordinator, reviews existing literature, clinical trials, and guidelines to inform CRF development.</p>
                </div>
                <div class="timeline-item">
                    <h3>6. WHO Consultation</h3>
                    <p>The CCP Coordinator or their delegate will contact WHO to obtain a copy of any related WHO CRFs, then discuss how the CRF and research questions can support WHOâ€™s 
                        related initiatives and what parties should be involved in its development. WHO feedback will be incorporated as much as possible by iteration of the required steps above or below.</p>
                </div>
                 <div class="timeline-item">
                    <h3>7. Framing Research Questions and CRF Content</h3>
                    <p>Working with the relevant Experts Reviewers, the CRF Initiator will define the research questions to be addressed by the CRF and map the relevant variables needed
                        to address these questions. </p>
                </div>
                     <div class="timeline-item">
                    <h3>8.Create First Draft CRF </h3>
                    <p>Using ISARIC BioResearch Integrated Data Tool Generator (<a href="https://bridge.isaric.org/">  BRIDGE </a>), the Initiator will develop an initial version of the CRF incorporating identified data points and
                        standardised variables from the ISARIC Analysis and Research Compendium (<a href="https://github.com/ISARICResearch/ARC"> ARC </a>.
                         Variables that do not have existing structures in ARC will be drafted by the CRF Initiator and relevant experts.   </p>
            
                </div>
                 <div class="timeline-item">
                    <h3>9.Experts Review of First Draft </h3>
                    <p> The first draft will be shared with Experts Reviewers via a shared web platform. Comments and edits will be invited during a review period defined by the Initiator, 
                        relative to the urgency of the need for the CRF. All reviewers will be invited to add their names to the reviewer list on the CRF for attribution of input.   </p>
                </div>
                  <div class="timeline-item">
                    <h3>10.Consider disease/syndromic relevance to CEPI  </h3>
                    <p>If within CEPI's scope of interest, the CCP Coordinator or their delegate share a copy of the CRF to request review and the addition of any variables that are 
                        valuable to CEPI's activities.  </p>
                </div>
                   <div class="timeline-item">
                    <h3>11.Completion of First Draft CRF  </h3>
                    <p>On completion of the review period, the Initiator will review all Expert Reviewers comments and, in consultation with individuals they deem informative, take decisions
                        to create a final first draft CRF. This version will be endorsed by the ISARIC Approvers comittee before progressing to the piloting.  </p>
                </div>
                  <div class="timeline-item">
                    <h3>12.	CRF Piloting  </h3>
                    <p>A REDCap project will be set up by ISARIC to enable end-users or colleagues to enter data and identify any usability issues. Feedback on any issues or improvements
                        needed will be collected and necessary adjustments made. </p>
                </div>
                    <div class="timeline-item">
                    <h3>13.	Completion of Final Version for Release  </h3>
                    <p>On completion of the piloting period, the feedback of the users are integrated and a final version of the CRF is created. This version will be endorsed by the ISARIC Approvers Committee. </p>
                </div>
                 <div class="timeline-item">
                    <h3>14.	Release </h3>
                    <p>The final version will be incorporated  as an ARChetype CRF in BRIDGE and communicated via ISARIC communications channels including direct email to all contributing Stakeholders,
                        as well as the newsletter.  </p>
                </div>
                
            </div>
        </section>
        <p><i> Last update:  <div id="demo"></div> </i></p>
    </div>

    <div class="footer">
        <p style="color:White"> If you are interested in using or developing an ARCHetype CRF,  please contact <a href="mailto:data@isaric.org">data@isaric.org</a></p>
    </div>
    
</body>
</html>
